Nebius Tanked This Month: A Resolute Wall Street Pro Expects 95% Gains Over The Next Twelve
📉 NBIS shares fell 23% this month to $212.19 amid a sector-wide neocloud selloff, widening the gap between price and analyst targets.
🚀 Q2 revenue surged 454% year-over-year to $582 million, beating consensus estimates of $574.65 million.
💰 The AI Cloud segment posted a robust 50% adjusted EBITDA margin in the second quarter.
📜 Management confirmed a massive $40 billion contracted backlog and $37.5 billion in remaining performance obligations.
🎯 Arete Research raised its price target to $415, implying 96% upside from current trading levels.
📈 Consensus Wall Street analysts maintain an average price target of $290.71, suggesting 37% upside.
🔮 Management reiterated 2026 revenue guidance of $3.0 billion to $3.4 billion and year-end ARR targets of $7B-$9B.
⚠️ Investors are concerned about high H1 capex spending of $8.13 billion and rising customer concentration risks.
📉 The stock trades at a forward P/E of 46x, reflecting rich valuation expectations for future growth.
🏆 Nebius is positioned as one of the few independent providers building multi-gigawatt capacity for AI training.
- Q2 revenue exploded 454% year-over-year to $582 million, significantly beating analyst consensus estimates.
- The company achieved a high-margin 50% adjusted EBITDA margin in its AI Cloud segment during Q2.
- Arete Research raised its price target to $415, implying nearly double the current stock price based on strong fundamentals.
- Management confirmed a massive $40 billion contracted backlog, providing a durable revenue pipeline for future years.
- The company successfully cleared a capacity auction at prices 15% higher than previous highs, validating Blackwell pricing power.
- Analysts view the recent stock decline as profit-taking rather than a fundamental breakage of the business thesis.
- The stock dropped 23% this month, widening the gap between current price and analyst targets due to sector-wide selling.
- Investors are concerned about high capital intensity, with an H1 capex bill of $8.13 billion potentially pressuring cash flow.
- Customer concentration remains a risk, as three customers accounted for 49% of total Q2 revenue combined.
- The stock trades at a rich forward P/E of 46x and price-to-sales ratio of 42x, requiring flawless execution to justify.